Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 9, Pages e0163699
Publisher
Public Library of Science (PLoS)
Online
2016-09-30
DOI
10.1371/journal.pone.0163699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
- (2015) Mei-Yin Zhang et al. BMC CANCER
- The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer
- (2015) Cillian Clancy et al. Cancer Biomarkers
- MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN
- (2015) Li-Juan Wang et al. Oncotarget
- Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
- (2015) Ryo Yamashita et al. Cancer Medicine
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies
- (2014) Kailiu Wu et al. TUMOR BIOLOGY
- Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma
- (2014) Li-yuan Qian MEDICAL SCIENCE MONITOR
- MicroRNA-21 Regulates the Invasion and Metastasis in Cholangiocarcinoma and May Be a Potential Biomarker for Cancer Prognosis
- (2013) Qiang Huang et al. Asian Pacific Journal of Cancer Prevention
- Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
- (2013) Minhua Rong et al. BMC CANCER
- miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma
- (2013) Na Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
- (2013) Yizhou Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance
- (2013) K Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
- (2013) Guang-Hui Liu et al. TUMOR BIOLOGY
- Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma
- (2012) Dario Ribero ARCHIVES OF SURGERY
- Systemic mirnas as potential biomarkers for malignancy
- (2012) N.A. Healy et al. INTERNATIONAL JOURNAL OF CANCER
- The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors
- (2012) Bing Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
- (2012) Haiyan Si et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
- (2012) Hala Faragalla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
- (2011) S Komatsu et al. BRITISH JOURNAL OF CANCER
- Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma
- (2011) I. Akagi et al. DISEASES OF THE ESOPHAGUS
- Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
- (2011) Niels H.H. Heegaard et al. INTERNATIONAL JOURNAL OF CANCER
- Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
- (2011) Mechteld C. de Jong et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- MicroRNA history: Discovery, recent applications, and next frontiers
- (2011) Maria I. Almeida et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?
- (2011) Nancy E. Kemeny et al. ONCOLOGY
- Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality
- (2010) Udo Rudloff et al. ANNALS OF SURGICAL ONCOLOGY
- MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
- (2010) Lei Shi et al. BRAIN RESEARCH
- AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma
- (2010) Olivier Farges et al. CANCER
- MicroRNA in colorectal cancer: from benchtop to bedside
- (2010) W. K. K. Wu et al. CARCINOGENESIS
- MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)
- (2010) Ji-guang Zhang et al. CLINICA CHIMICA ACTA
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- (2010) Evan M. Kroh et al. METHODS
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
- (2009) W. R. Jarnagin et al. ANNALS OF ONCOLOGY
- MicroRNAs and Cancer: Short RNAs Go a Long Way
- (2009) Andrea Ventura et al. CELL
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
- (2009) Florin M. Selaru et al. HEPATOLOGY
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
- (2008) T. Papagiannakopoulos et al. CANCER RESEARCH
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
- MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
- (2008) Mary Dillhoff et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
- (2008) Lei Chen et al. JOURNAL OF HEPATOLOGY
- MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
- (2008) Z Lu et al. ONCOGENE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started